Search

everythinglearnresearchcommunity

for

Search:↓

Proxalutamide helps COVID-19 patients get rid of the virus faster and recover quicker.

Formestane is a preferred second-line treatment for advanced breast cancer in postmenopausal women because it's effective and has fewer side effects.

GnRH-a or orchiectomy is more effective than anti-androgens for managing hormone levels in transgender women.

A woman's excessive hair growth was linked to a rare case of high testosterone caused by a prolactin-producing pituitary tumor.

Leflunomide successfully treated a rare skin condition in a liver transplant patient.

Hormonal male contraception is effective and could be market-ready, but more research is needed to ensure safety for all ethnic groups.

Exposure to certain sex hormones can increase health risks, while some hormone therapies may offer benefits for specific conditions.

The E2 protein affects gene activity in hair follicles of mice.

A new model helps predict treatment success in girls with early puberty.

Pegylated liposomal doxorubicin is as effective as conventional doxorubicin but causes fewer heart problems and side effects.

LY191704 is a compound that effectively blocks a specific enzyme involved in hormone conversion and could help treat enlarged prostate and hair loss.

Some birth control pills increase blood clot risk; use them for specific conditions only.

IVL-DrugFluidic® can mass-produce high-quality, long-acting injectable drug microspheres, improving patient compliance and reducing side effects.

All four treatments for early rheumatoid arthritis had similar safety profiles.

Don't combine abiraterone and spironolactone for prostate cancer treatment as it may worsen the disease.

The treatment combination is effective and generally safe for lung cancer.

Lenalidomide effectively and safely treats skin symptoms in pediatric lupus, reducing the need for prednisone.

Platelet-rich plasma may improve embryo genetics in IVF.

Liposomes can make the antiandrogen RU 58841 more effective for skin application by reducing absorption, increasing skin retention, and targeting sebaceous structures.

Anifrolumab improves quality of life and reduces steroid use in lupus patients.

The method effectively showed that the two exemestane preparations are bioequivalent.

The study found that prescribing patterns for Cyproterone Acetate/Ethinylestradiol in Italy did not significantly change after EMA recommendations.

Belimumab effectively controls SLE disease activity and reduces steroid use.

Further testing of paclitaxel poliglumex for this cancer treatment is not justified.

New treatments for male hypogonadism are effective and should be personalized.

A brain-made hormone can protect against memory-related brain damage caused by harmful proteins.